Sponsor Dossier
Hugel
Sponsor Dossier for Hugel. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: LETYBO
- Device (sponsor): REVOLAX™ FINE with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): REVOLAX™ SUB-Q with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): REVOLAX™ DEEP with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Princess Volume Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Princess Filler - Dermal tissue reconstructive material, microbe-derived
- Device (sponsor): Princess Rich - Dermal tissue reconstructive material, microbe-derived
- Device (sponsor): Princess Volume Plus Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Princess Volume - Dermal tissue reconstructive material, microbe-derived
- Device (sponsor): Princess Filler Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Cannula, tissue injection
About
Hugel is an Australian Private Company with ABN 93159477988, registered in New South Wales. The entity is active and has traded under the business names HUGEL AESTHETICS and CROMA Australia.
Portfolio
Hugel has one brand on the ARTG, which is indexable. The portfolio includes one brand with Product Information on file. No brands are PBS-listed, and no brands have PBAC outcomes on record. One brand has an AusPAR on record.
Therapeutic focus
— Dermatology: 1 brand
Regulatory activity
Hugel's latest AusPAR was published on 23 November 2022.